Wasn't the CRO, Amarex, responsible for tracking the patients and recording the data from the trial? Have they turned over the data yet? I don't believe so, and if not, that would easily explain why NP said they may have to contact the patients to determine their current status.

Quote:

---

not staying on top of the survival rate for the past 4 months was a bit of a surprise, and that is an understatement . symptom of two many balls in the air and a stretched staff perhaps ?

---